Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions

Cervera, R; Tektonidou, MG; Espinosa, G; Cabral, AR; Gonzalez, EB; Erkan, D; Vadya, S; Adrogue, HE; Solomon, M; Zandman-Goddard, G; Shoenfeld, Y

dc.contributor.author	Cervera, R	en
dc.contributor.author	Tektonidou, MG	en
dc.contributor.author	Espinosa, G	en
dc.contributor.author	Cabral, AR	en
dc.contributor.author	Gonzalez, EB	en
dc.contributor.author	Erkan, D	en
dc.contributor.author	Vadya, S	en
dc.contributor.author	Adrogue, HE	en
dc.contributor.author	Solomon, M	en
dc.contributor.author	Zandman-Goddard, G	en
dc.contributor.author	Shoenfeld, Y	en
dc.date.accessioned	2014-03-01T02:07:07Z
dc.date.available	2014-03-01T02:07:07Z
dc.date.issued	2011	en
dc.identifier.issn	0961-2033	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/29517
dc.subject	Catastrophic antiphospholipid syndrome	en
dc.subject	nephropathy	en
dc.subject	heart valve lesions	en
dc.subject	antiphospholipid antibodies	en
dc.subject.classification	Rheumatology	en
dc.subject.other	SYSTEMIC-LUPUS-ERYTHEMATOSUS	en
dc.subject.other	INTERNATIONAL CONSENSUS STATEMENT	en
dc.subject.other	ANTICARDIOLIPIN ANTIBODIES	en
dc.subject.other	VALVULAR DISEASE	en
dc.subject.other	LONG-TERM	en
dc.subject.other	TRANSESOPHAGEAL ECHOCARDIOGRAPHY	en
dc.subject.other	TRANSTHORACIC ECHOCARDIOGRAPHY	en
dc.subject.other	CLASSIFICATION CRITERIA	en
dc.subject.other	CARDIAC MANIFESTATIONS	en
dc.subject.other	GLOMERULAR THROMBOSIS	en
dc.title	Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions	en
heal.type	journalArticle	en
heal.language	English	en
heal.publicationDate	2011	en
heal.abstract	The objectives of the 'Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations' were to assess the clinical utility of the international consensus statement on classification criteria and treatment guidelines for the catastrophic APS, to identify and grade the studies that analyse the relationship between the antiphospholipid antibodies and the non-criteria APS manifestations and to present the current evidence regarding the accuracy of these non-criteria APS manifestations for the detection of patients with APS. This article summarizes the studies analysed on the catastrophic APS, APS nephropathy and heart valve lesions, and presents the recommendations elaborated by the Task Force after this analysis. Lupus (2011) 20, 165-173.	en
heal.publisher	SAGE PUBLICATIONS LTD	en
heal.journalName	LUPUS	en
dc.identifier.isi	ISI:000287078600010	en
dc.identifier.volume	20	en
dc.identifier.issue	2	en
dc.identifier.spage	165	en
dc.identifier.epage	173	en